Related Experiment Video
Updated: Mar 20, 2026

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
[Safety of long-term nicotine use: An ongoing debate]
P Dupont1, A Benyamina1, H-J Aubin1
1Inserm U669, centre d'addictologie, hôpital Paul-Brousse, Assistance publique-Hôpitaux de Paris, université Paris-Sud, 14, avenue P.V.-Couturier, 94804 Villejuif, France.
Long-term nicotine use as a smoking risk-reduction strategy is debated. Nicotine may contribute to atherosclerosis, cancer, and apoptosis reduction, warranting further safety assessments.
Area of Science:
- Toxicology
- Pharmacology
- Public Health
Background:
- Long-term nicotine use is explored as a harm reduction approach for smokers unable or unwilling to quit.
- The safety profile of sustained nicotine exposure remains a significant public health concern.
Purpose of the Study:
- To evaluate the safety of long-term nicotine use.
- To assess the risk-benefit balance of nicotine in smoking cessation and risk reduction.
Main Methods:
- Comprehensive literature review of publications from PubMed, Toxibase, and Google Scholar.
- Inclusion of data from regulatory agency websites (FDA, HAS).
Main Results:
- Nicotine is potentially implicated in atherosclerosis development.
- Evidence suggests nicotine may act as a cancer precursor, promoting proliferation and angiogenesis while inhibiting apoptosis.
- Nicotine may possess genotoxic properties.
Conclusions:
- The safety of long-term nicotine use cannot be definitively established.
- A thorough risk-benefit assessment is crucial, particularly within the context of risk-reduction strategies.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Depressants: Alcohol and Nicotine
Stress Prevention and Stress Management Techniques IV
Longitudinal Research
Toxicity Testing in Animals